Dr. Nandini Selvam Joined Harvard Medical School Faculty
The IQVIA executive has taken on new roles at the Harvard Medical School and Harvard Pilgrim Health Care Institute.
Updated on Sept. 21, 2026 in People
Dr. Nandini Selvam has officially joined the faculty at Harvard Medical School and the Harvard Pilgrim Health Care Institute. Her appointment follows a decade of professional collaboration with researchers at the institution.
Why it matters
The new position allows Dr. Selvam to deepen her focus on vaccine safety, regulatory science, and the analysis of real-world health data. She intends to use this role to foster new research partnerships and mentor the next generation of public health professionals.
Dr. Selvam brings over 10 years of professional collaboration with the institute to this new faculty role. She earned her PhD in Epidemiology from Rutgers University and previously served as an Epidemic Intelligence Service Officer at the CDC.
The players
Dr. Nandini Selvam
She serves as the President of IQVIA Government Solutions and holds a PhD in Epidemiology from Rutgers University.
Harvard Medical School
It is a graduate medical school in Boston that is part of Harvard University.
Harvard Pilgrim Health Care Institute
This institute is a research and teaching organization that focuses on population medicine and health policy.
CDC
The Centers for Disease Control and Prevention is the national public health agency of the United States.
The details
Dr. Selvam currently serves as the President of IQVIA Government Solutions, a role she maintains alongside her new academic responsibilities. In her capacity at the Department of Population Medicine, she will contribute to critical studies in vaccine safety and regulatory science.
Timeline
The appointment of Dr. Nandini Selvam was announced on September 21, 2026.
Market Landscape
This appointment highlights the growing permeability between private sector pharmaceutical intelligence and academic public health research. The move strengthens the industry-academic pipeline established by the Harvard Pilgrim Health Care Institute's Department of Population Medicine.
Students and researchers in the Boston area may see increased opportunities for mentorship and collaboration through Dr. Selvam's new faculty role. Her dual work in the private sector and academia may also accelerate the development of real-world data analysis tools.
The takeaway
Dr. Selvam’s transition illustrates how senior industry executives are increasingly shaping the direction of academic research in regulatory science. Professionals in public health can look to her career path as a model for balancing corporate leadership with institutional scholarship.
Further reading
Learn more about local industry moves in our People section.
Source note: This article includes information reported by The American Bazaar.
